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OBJECTIVE — Caudate magnetization transfer (MT) ratios have indicated an abnormality in
the macromolecular protein pool of diabetic patients. This study examined the relationship
between MT ratios of the caudate and cognitive performance.
RESEARCH DESIGN AND METHODS — Diabetic patients, diabetic and depressed
patients, and healthy comparison subjects completed magnetic resonance imaging and a neu-
ropsychological battery. Magnetization transfer ratios of caudate and three comparison regions
were computed. The neuropsychological battery was aggregated into a global index of cognitive
function and correlated with MT ratios.
RESULTS — MT ratios of the caudate correlated with cognitive performance, and the corre-
lations were stronger among diabetic patients than healthy control subjects. Comorbid depres-
sionincreasedthestrengthofthecorrelationcomparedwithdiabetesalone.Comparisonregions
showed no evidence of a diabetes effect on cognition.
CONCLUSIONS — One mechanism precipitating cognitive loss during diabetes appears to
beassociatedwithcellularchangesoccurringinthemacromolecularproteinpoolofthecaudate.
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M
agnetization transfer (MT) is a
magnetic resonance imaging
(MRI)-related approach used to
study the biological integrity of myelin
and axonal density in the white matter
andacompositeindexofmacromolecular
proteins in gray matter regions. A recent
reportfromourlaboratoryusingMTdoc-
umented a decline in the saturated signal
intensity of macromolecular proteins in
the head of the caudate in diabetic pa-
tients that is exacerbated in patients with
concurrent depression (1). Conse-
quently, diabetes is associated with some
lossofcellularintegrityinthecaudatedue
to macromolecular protein dysfunction.
This study examined the relationship
between cognitive functioning of diabetic
patients and MT ratios from caudate and
three comparison regions: putamen, dor-
solateral periventricular white matter,
and anterior cingulate. The rich and di-
verse communication pathways (2,3)
passing through the caudate are impor-
tantforseveralaspectsofcognition,sowe
hypothesized that global cognitive func-
tionwouldbeassociatedwithcaudateMT
ratios.Theothercomparisonregionspro-
videdinformationonthespeciﬁcityofthe
cognition-caudate association.
RESEARCH DESIGN AND
METHODS— An ongoing study on
diabetes and depression is being con-
ducted at UCLA Medical Center. De-
pressed and nondepressed patients were
under care provided at UCLA clinics af-
ﬁliated with departments of internal
medicine and endocrinology. Subjects
were screened with the Structured Clin-
ical Interview for DSM-IV (SCID) (4),
the Mini Mental Status Examination
(MMSE), the American Heart Associa-
tion’s Stroke Risk Prediction Chart
(CVRF) (5), and the Cumulative Illness
Rating Scale (CIRS) (6). Participants
completed an electrocardiogram and a
standard battery of laboratory tests. The
study protocol was approved by the
UCLA Institutional Review Board.
Please see Elderkin-Thompson et al.
(7) and Kumar et al. (8) for complete
procedures.
Neuropsychological battery
The neuropsychological battery included
tests of working memory (Letter-Number
Sequences), language (Controlled Oral
Word Association, or FAS), simple atten-
tion and processing (Stroop 1 and 2,
Trailmaking A, Digit Symbol Substitu-
tion), procedural learning (Wisconsin
Card Sorting Test), executive function
(MatrixReasoning,TrailmakingB,Stroop
Interference), visuospatial conceptualiza-
tion (Block Designs), and declarative
learning and recall (California Verbal
Learning Test, trials 1–5, short and de-
layed recall). Cronbach’s0.90 for the
composite global scale indicated good
reliability.
Methods
MRIwasperformedwitha1.5Teslascan-
ner (Signa, Lx echospeed plus 9.1; Gen-
eral Electric Medical System, Milwaukee,
WI) using a transmit/receive quadrature
head coil. Imaging was performed in an
axial plane using fast-spin echo T2 and
MT T1 weighted sequences. Details on
MRI acquisition and MT methods have
been previously reported (9,10). In MT
imaging, an off-resonance radio fre-
quency pulse is used to minimize the ex-
change of protons between bound water
(bound to macromolecular proteins) and
free water compartments in the brain
(11,12). The resulting image is a subtrac-
tion of the image with the RF pulse from
the original one without the pulse.
Statistical plan
Demographic and clinical variables were
analyzedwithANOVAsandposthoccon-
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groups were compared using CIRS as a
covariate because diagnostic groups dif-
fered in their symptom counts. CIRS,
CVRF, and short-form (SF)-36 were
highly intercorrelated, so CIRS was se-
lected as the most representative of gen-
eral health status. Cognitive scores were
standardized, with higher scores repre-
senting better performance and tested for
homogeneity (Cronbachs 0.89). The
global cognitive scale was correlated with
MTratiosafterCIRSadjustment.Brainre-
gions that correlated with the cognitive
index were examined by plotting the MT
ratio by the cognitive index.
RESULTS— Diagnostic groups dif-
fered on global cognition, with both dia-
betic groups performing signiﬁcantly
below the comparison group and de-
pressed performing signiﬁcantly below
nondepresseddiabeticpatients.MTratios
from the caudate differed across diagnos-
tic groups and formed the same step de-
cline of means observed in the cognitive
index.
Correlations
MT ratios of caudate and putamen corre-
latedwiththecognitiveindexafteradjust-
ment for CIRS total symptom count
(caudate, r [59]  0.36, P  0.006; pu-
tamen, r [59]  0.44, P  0.001). Corre-
lations remained signiﬁcant after
Bonferroni’s correction (0.0125).
Correlation coefﬁcients for the remaining
regions were small to trivial.
In the subgroup analysis, healthy
comparison individuals did not demon-
strate a relationship between cognition
andcaudateMTratios(r[28]0.24,P
0.23). Diabetic patients as a group did
show a relationship (r [31]  0.37, P 
0.04), but there was no signiﬁcant differ-
ence between the correlations of control
subjects and patients (Fisher’s z differ-
ence  0.52, P  0.60). When the dia-
betic group was further subdivided into
depressed and nondepressed patients,
only the depressed diabetic subjects
showedanassociation(r[13]0.56,P
0.05), but this also was not signiﬁcantly
different from healthy comparison sub-
jects (z difference  1.04, P  0.30).
In the putamen, control subjects
demonstrated no linear relationship be-
tween MT ratios and cognition (r [28] 
0.08,P0.70).Diabeticpatientsshowed
a relationship (r [31]  0.59, P  0.001),
which was signiﬁcantly different from
healthy control subjects (Fisher’s z differ-
ence  2.17, P  0.03). In the patient
subgroups, both nondepressed and de-
pressed diabetic patients showed an asso-
ciation (r [18]  0.50, P  0.04; r [13] 
0.66, P  0.01, respectively), although
neither correlation was signiﬁcantly dif-
Table 1—Between-group differences of demographic and clinical characteristics
Depressed diabetic Diabetic comparison Healthy comparison F (df  2,56)* P
n 13 18 28
Age 59.46  11.41 62.00  9.47 55.04  11.00 2.47 0.09
Education 14.85  2.08 15.22  2.67 16.43  3.18 1.79 0.18
CIRS (total symptoms) 7.23  2.62† 6.78  3.80‡ 2.57  2.20 17.47 0.01
SF-36 (general health) 42.30  25.46†§ 73.06  16.73‡ 85.54  12.42 27.84 0.01
CVRF (age adjusted) 11.08  3.08† 9.72  3.14‡ 3.36  3.73 28.48 0.01
Diabetes age of onset 49.18  16.27 52.23  10.08 NA 0.38 0.54
Diabetes duration (months) 140.73  114.23 115.76  95.99 NA 0.39 0.54
Depression age of onset 53.91  12.70 NA NA
Depression duration 84.18  66.13 NA NA
Ham-D 20.45  4.32 NA NA NA NA
A1C 7.46  1.53†§ 6.70  1.09‡ 5.40  0.43 19.58 0.01
Mini Mental Status Examination 27.38  2.90† 28.61  1.78 29.07  1.15 3.71 0.03
Global cognition (z score) 0.46  0.74†§ 0.13  0.58‡ 0.29  0.53 7.44 0.01
MT ratio
Bilateral caudate 29.06  2.56†§ 32.26  2.08‡ 35.14  1.05 31.41 2,55 0.001
Bilateral putamen 33.57  2.23 33.82  1.38 35.08  0.98 2.42 2,55 0.10
Frontal periventricular 43.58  1.41 43.85  1.65 44.29  1.73 0.13 2,55 0.88
White matter
Anterior cingulate 25.06  5.01 26.63  3.87 27.99  3.58 0.38 2,54 0.69

2 P
Sex 
2 21.49 0.47
Male 2 (15) 6 (33) 6 (21)
Female 11 (85) 12 (67) 22 (79)
Ethnicity 
2 89.90 0.27
African American 2 (15) 4 (22) 3 (11)
Latino 2 (15) 2 (11) 1 (4)
Asian 3 (23) 3 (17) 3 (11)
Caucasian 5 (38) 7 (39) 21 (75)
Other 1 (8) 2 (11) 0
DataaremeansSDorn(%).*dfof2,56appliedtoallanalysesunlessotherwisestated.Ham-D,HamiltonRatingScaleforDepression;SF-36GeneralHealth,RAND
SF-36 Short Form General Health subtest. †Difference between depressed diabetic patients and healthy comparison subjects, P  0.01. ‡Difference between
nondepresseddiabeticgroupandhealthycomparisonsubjects,P0.05.§Differencebetweennondepresseddiabeticgroupanddepresseddiabeticgroup,P0.05.
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(z  1.44, P  0.15; z  1.90, P 	 0.05).
Scatterplots (not provided) demon-
strated the different patterns of associa-
tion for the two regions. In the caudate,
data points of diagnostic groups showed
some segregation with three apparent
clusters of scores, consistent with signiﬁ-
cant mean differences. The healthy com-
parison group was clustered primarily
above the MT and cognition means, de-
pressed diabetic subjects were largely be-
low both means, and nondepressed
diabetic subjects were grouped at the
means. In the putamen, the data points
from the groups were interspersed with
no group mean differences.
CONCLUSIONS — As hypothesized,
global cognitive performance correlated
with caudate MT ratios. The ﬁnding that
the MT-cognition correlation was stron-
ger among patients then among healthy
comparisonsubjects,andstrongeramong
depressed diabetic patients than nonde-
pressed diabetic patients, suggests a
threshold pattern in which the MT effect
is modest but notable when only diabetes
is present, but it becomes exacerbated
when both diabetes and depression are
present. MT ratios from the putamen cor-
related with global cognition, but the
means did not differ between groups, so
there was no obvious disease effect. Al-
though interpretation of low MT ratios in
white and gray matter are not yet under-
stood, physiological abnormalities in cell
membranes and proteins together with
neuronal and synaptic loss are currently
posited as explanations for differences.
A methodological caution results
fromthesmallsamplesizeandlowpower
of the analysis. Differences between
groups may become signiﬁcant with a
largersample,andtheroleoftheputamen
deservesfurtherstudy.Inconclusion,our
results, although preliminary, suggest
thatonemechanismunderlyingmildcog-
nitivedeclineindiabetesmaylieinabnor-
malitiesoftheproteinbiochemistryofthe
caudate.
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